Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
Future Medicinal Chemistry
|
August 10, 2018
Hypoxia-inducible factor 2α: a novel target in gliomas
Jaclyn J Renfrow, Michael H Soike, Waldemar Debinski, et al.
Journal of Medicinal Chemistry
|
November 14, 2009
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease
Ajit Jadhav, Rafaela S Ferreira, Carleen Klumpp, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 4, 2013
In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility
Rebecca S Treger, Joseph Otchere, Martin F Keil, et al.
Journal of Neuro-Oncology
|
October 12, 2010
Radiation-induced adult medulloblastoma: a two-case report and review of the literature
Michael D Chan, Albert Attia, Stephen B Tatter, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
September 18, 2017
Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control
Ammoren Dohm, Emory R McTyre, Michael D Chan, et al.
Journal of Medicinal Chemistry
|
December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine
Rachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)
Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 30, 1994
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?
R T Oliver, P M Edmonds, J Y Ong, et al.
Oncology Letters
|
August 11, 2022
<i>PTCH1</i> mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report
John T Dorsey, Ryan T Mott, Christopher M Lack, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
Future Medicinal Chemistry
|
August 10, 2018
Hypoxia-inducible factor 2α: a novel target in gliomas
Jaclyn J Renfrow, Michael H Soike, Waldemar Debinski, et al.
Journal of Medicinal Chemistry
|
November 14, 2009
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease
Ajit Jadhav, Rafaela S Ferreira, Carleen Klumpp, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 4, 2013
In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility
Rebecca S Treger, Joseph Otchere, Martin F Keil, et al.
Journal of Neuro-Oncology
|
October 12, 2010
Radiation-induced adult medulloblastoma: a two-case report and review of the literature
Michael D Chan, Albert Attia, Stephen B Tatter, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
September 18, 2017
Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control
Ammoren Dohm, Emory R McTyre, Michael D Chan, et al.
Journal of Medicinal Chemistry
|
December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine
Rachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)
Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 30, 1994
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?
R T Oliver, P M Edmonds, J Y Ong, et al.
Oncology Letters
|
August 11, 2022
<i>PTCH1</i> mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report
John T Dorsey, Ryan T Mott, Christopher M Lack, et al.
Page
of 12